Related Experiment Video
Updated: Jul 24, 2025

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
U-shaped association of serum magnesium with mild cognitive impairment among hemodialysis patients: a multicenter
Yuqi Yang1, Yanjun Long1, Jing Yuan1
1Department of Nephrology, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China.
Background:
The optimal serum magnesium level of patients undergoing hemodialysis (HD) with cognitive impairment is still unclear. This study aimed to evaluate the association between serum magnesium levels and mild cognitive impairment among HD patients.
Methods:
This was a multicenter observational study. Patients undergoing hemodialysis from 22 dialysis centers in Guizhou Province, China were recruited into the study. HD patients were divided into five groups according to serum magnesium quintile. Cognitive function was measured with Mini Mental State Examination. The outcome was an incident mild cognitive impairment (MCI). Multivariate logistic regression analysis, restricted cubic spline and subgroup analysis were applied to explore the association of serum magnesium level with MCI.
Results:
Among 3562 HD patients (mean age 54.3 years, 60.1% male), the prevalence of MCI was 27.2%. After adjusting for confounders, serum magnesium 0.41-0.83 mmol/L [odds ratios (OR) 1.55, 95% confidence interval (CI): 1.10-2.18] had a higher risk of MCI compared with serum magnesium of 1.19-1.45 mmol/L. A U-shaped association was identified between the serum magnesium and incident MCI (P for non-linearity = 0.004). The optimal range of magnesium level with the lowest risk of MCI was 1.12-1.24 mmol/L. As the serum magnesium level was lower than 1.12 mmol/L, the risk of MCI decreased by 24% per standard deviation (SD) increase in serum magnesium (OR 0.76, 95%CI: 0.62-0.93); when the serum magnesium level exceeds 1.24 mmol/L, a rise per SD increased the risk of MCI by 21% (OR = 1.20, 95%CI: 1.02-1.43). Subgroup analyses demonstrated that the associations were robust among individuals with low educational level, smoking, living alone, no working, and without hypertension or diabetes.
Conclusions:
Serum magnesium has a U-shaped association with MCI among HD patients. Both lower and higher serum magnesium can increase the risk of MCI for this population specifically. The optimal serum magnesium range with the lowest risk of MCI was 1.12-1.24 mmol/L.
More Related Videos
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Serum Studies: Renal Function Tests
Hemodialysis II: Procedure and Complications
Chronic Kidney Disease III: Interprofessional Care
Hemodialysis III: Nursing Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention

